• Simon Brooks' profile

    I'm male and 28 London

    • What I do

      My undergraduate and postgraduate degrees were in molecular biology and genetics, respectively. I’m now two thirds through my first postdoctoral position, working at the Institute of Ophthalmology, where I also did my PhD. My current research interest stems from my Ph.D. in which I independently identified the NHS gene as the underlying cause of Nance-Horan Syndrome (NHS). NHS is an X-linked developmental syndrome characterised by congenital cataract, dental anomalies and dysmorphological features often associated with mental retardation. I’m currently funded by the Wellcome Trust to investigate the function of the NHS protein in ocular and craniofacial development.

    • Affiliations

      Current

    • Interests

      No interests have been listed by Simon Brooks.

    • Projects

      Simon Brooks has not yet listed any projects.

    • Publications

      • Brooks S, Ebenezer N, Poopalasundaram S, Lehmann O, Moore A, Hardcastle A. Identification of the gene for Nance-Horan syndrome (NHS). Journal of medical genetics 41 (10) , 768-71 PubMed ID:(15466011 )

      • Brooks S, Ebenezer N, Poopalasundaram S, Maher E, Francis P, Moore A, Hardcastle A. Refinement of the X-linked cataract locus (CXN) and gene analysis for CXN and Nance-Horan syndrome (NHS). Ophthalmic genetics 25 (2) , 121-31 PubMed ID:(15370543 )

      • Florijn R, Loves W, Maillette de Buy Wenniger-Prick L, Mannens M, Tijmes N, Brooks S, Hardcastle A, Bergen A. New mutations in the NHS gene in Nance-Horan Syndrome families from the Netherlands. European journal of human genetics : EJHG 14 (9) , 986-90 (Epub 31 May 2006) PubMed ID:(16736028 )

      • Huang K, Wu J, Brooks S, Hardcastle A, Lewis R, Stambolian D. Identification of three novel NHS mutations in families with Nance-Horan syndrome. Molecular vision 13 , 470-4 (Epub 27 Mar 2007) PubMed ID:(17417607)

      • Thiselton D, Alexander C, Morris A, Brooks S, Rosenberg T, Eiberg H, Kjer B, Kjer P, Bhattacharya S, Votruba M. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. Human genetics 109 (5) , 498-502 (Epub 03 Oct 2001) PubMed ID:(11735024 )

      view all
Sign in

New to Nature Network?
Sign up today!

Search people
Send an invite

Advertisement